Filter
247
Filtered Results: 247
Text search:
Zhu,
Y.
et
al.
Featured
Recommendations
27
New Publications
14
Language
Document type
Studies & Reports
79
Guidelines
77
No document type
62
Fact sheets
16
Manuals
10
Training Material
1
Infographics
1
Strategic & Response Plan
1
Countries / Regions
Russia
17
Brazil
10
Global
9
Latin America and the Carribbean
7
Middle East and North Africa
7
Syria
5
Yemen
5
Kenya
4
Germany
4
Eastern Europe and Central Asia
4
Spain
4
South Sudan
4
Ecuador
4
India
4
Chile
3
Mozambique
3
Africa
3
Argentina
3
South Africa
3
Vietnam
3
Angola
3
Ghana
2
Nigeria
2
Laos
2
Peru
2
Malawi
2
Cambodia
2
Guinea-Bissau
2
West and Central Africa
2
Western and Central Europe
2
Bangladesh
2
Eastern Europe
2
Nepal
1
Colombia
1
Ukraine
1
Lesotho
1
Benin
1
China
1
Rwanda
1
Senegal
1
Congo-Brazzaville
1
Philippines
1
USA
1
Haiti
1
Asia
1
Venezuela
1
Tanzania
1
Congo, Democratic Republic of
1
France
1
Portugal
1
East and Southern Africa
1
Uganda
1
Sudan
1
Ethiopia
1
Mali
1
Zambia
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
100
Public Health
18
Clinical Guidelines
17
Women & Child Health
3
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
COVID-19
102
Planetary Health
24
NCDs
17
TB
16
HIV
13
AMR
7
Mental Health
6
Disability
6
Pharmacy
5
Natural Hazards
4
NTDs
4
Conflict
4
Global Health Education
4
Rapid Response
3
Caregiver
3
Refugee
1
Ebola
1
Health Financing Toolbox
1
The Lancet, Planetary Health Volume 5, ISSUE 11, e766-e774, November 01, 2021
Increasing human demand for water and changes in water availability due to climate change threatens water security worldwide. Additionally, exploitation of water resources induces stress on freshwater environments, leadi...
In the light of the transmissibility of coronaviruses, and the global experience with MERS-CoV (ongoing) and SARS in 2003 which were also caused by coronaviruses, South African authorities have compiled this guideline document to support surveillance, case finding, diagnosis, management and public h...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical societies and contacted international organizations.
Co...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. This article wants to determine the burden (prevalence,
mortality, and activity and work impairment) of severe asthma in 3 countries in East Africa: Uganda, Kenya, and Ethio...
Extreme heat events (EHEs) are a leading cause of weather-related injury and death in the United States, and under a changing climate, these meteorological episodes are predicted to increase in both frequency and intensity. Prolonged heat exposure from EHEs places an increased strain on the heart an...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
La presente publicación describe la literatura científica revisada sobre las intervenciones farmacológicas para el tratamiento de la enfermedad por el coronavirus 2019. El Ministerio de Salud solicitó la revisión de la evidencia disponible para nueve intervenciones terapéuticas frente a COVID-...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
